Actiq oral transmucosal fentanyl regulatory update

NSTA's Anesta U.K. Ltd. subsidiary (London, U.K.) submitted a marketing authorization application (MAA) for U.K. approval of Actiq to manage breakthrough pain in patients receiving maintenance opioid ...